Jinping Li
Guangxi Key Laboratory Of Tumor Immunology And Microenvironmental Regulation
Guilin, China
Guilin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression.
Journal: Cellular signalling
Published: April 08, 2026
Deubiquitinating Enzyme UCHL1 Modulates FHL2 to Block Ferroptosis and Counteract CD8 + T Cell Anti-Tumour Immunity in Lung Adenocarcinoma.
Journal: Immunology
Published: February 18, 2025
E2F7 targets S100A2 to suppress CD8+T cell activity in lung adenocarcinoma by regulating glutamine metabolism.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: February 10, 2025
Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer.
Journal: Scientific reports
Published: February 05, 2025
The clinical significance and oncogenic function of LRRFIP1 in pancreatic cancer.
Journal: Discover oncology
Published: October 03, 2023
Aberrant expression of cuproptosis‑related gene LIPT1 is associated with metabolic dysregulation of fatty acid and prognosis in hepatocellular carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: July 29, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026